Study provides new insight on how HER2-low tumors may evolve in breast cancer patient

[News]

The finding that breast tumors can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low tumors.

More... (https://www.news-medical.net/news/20210508/Study-provides-new-insight-on-how-HER2-low-tumors-may-evolve-in-breast-cancer-patients.aspx)